Goldman Sachs’s AbbVie ABBV Stock Holding History

Goldman Sachs’s Portfolio ABBV Stock Details ABBV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.26B	Sell	12,168,462 -1,981,546	-14%	-$368M	0.31%	34
2025 Q1	$2.96B	Buy	14,150,008 +2,854,787	+25%	+$598M	0.48%	20
2024 Q4	$2.01B	Buy	11,295,221 +612,902	+6%	+$109M	0.32%	35
2024 Q3	$2.11B	Sell	10,682,319 -928,570	-8%	-$183M	0.34%	37
2024 Q2	$1.99B	Buy	11,610,889 +2,725,088	+31%	+$467M	0.34%	36
2024 Q1	$1.62B	Sell	8,885,801 -1,734,645	-16%	-$316M	0.29%	41
2023 Q4	$1.65B	Sell	10,620,446 -113,628	-1%	-$17.6M	0.3%	40
2023 Q3	$1.6B	Buy	10,734,074 +1,413,745	+15%	+$211M	0.34%	36
2023 Q2	$1.26B	Sell	9,320,329 -799,125	-8%	-$108M	0.27%	48
2023 Q1	$1.61B	Buy	10,119,454 +1,282,296	+15%	+$204M	0.37%	30
2022 Q4	$1.43B	Sell	8,837,158 -574,540	-6%	-$92.9M	0.35%	30
2022 Q3	$1.26B	Buy	9,411,698 +796,517	+9%	+$107M	0.32%	36
2022 Q2	$1.32B	Sell	8,615,181 -610,746	-7%	-$93.5M	0.33%	32
2022 Q1	$1.5B	Sell	9,225,927 -428,133	-4%	-$69.4M	0.31%	32
2021 Q4	$1.31B	Sell	9,654,060 -223,702	-2%	-$30.3M	0.26%	40
2021 Q3	$1.07B	Buy	9,877,762 +3,026,131	+44%	+$326M	0.23%	48
2021 Q2	$772M	Buy	6,851,631 +285,052	+4%	+$32.1M	0.17%	80
2021 Q1	$711M	Sell	6,566,579 -1,687,475	-20%	-$183M	0.18%	77
2020 Q4	$884M	Sell	8,254,054 -1,845,258	-18%	-$198M	0.23%	49
2020 Q3	$885M	Sell	10,099,312 -1,622,327	-14%	-$142M	0.25%	45
2020 Q2	$1.15B	Sell	11,721,639 -2,352,596	-17%	-$231M	0.35%	29
2020 Q1	$1.07B	Buy	14,074,235 +1,682,474	+14%	+$128M	0.38%	33
2019 Q4	$1.1B	Sell	12,391,761 -357,093	-3%	-$31.6M	0.28%	53
2019 Q3	$965M	Buy	12,748,854 +2,124,794	+20%	+$161M	0.28%	52
2019 Q2	$773M	Sell	10,624,060 -318,664	-3%	-$23.2M	0.22%	65
2019 Q1	$882M	Sell	10,942,724 -1,594,114	-13%	-$128M	0.27%	52
2018 Q4	$1.16B	Sell	12,536,838 -744,850	-6%	-$68.7M	0.37%	30
2018 Q3	$1.26B	Buy	13,281,688 +671,132	+5%	+$63.5M	0.32%	34
2018 Q2	$1.17B	Sell	12,610,556 -591,734	-4%	-$54.8M	0.32%	37
2018 Q1	$1.25B	Buy	13,202,290 +52,460	+0.4%	+$4.97M	0.32%	33
2017 Q4	$1.27B	Buy	13,149,830 +3,329,292	+34%	+$322M	0.3%	35
2017 Q3	$873M	Buy	9,820,538 +145,552	+2%	+$12.9M	0.21%	54
2017 Q2	$702M	Buy	9,674,986 +1,455,125	+18%	+$106M	0.18%	68
2017 Q1	$536M	Buy	8,219,861 +516,801	+7%	+$33.7M	0.15%	95
2016 Q4	$482M	Buy	7,703,060 +876,569	+13%	+$54.9M	0.14%	101
2016 Q3	$431M	Buy	6,826,491 +594,674	+10%	+$37.5M	0.13%	104
2016 Q2	$386M	Buy	6,231,817 +246,811	+4%	+$15.3M	0.13%	110
2016 Q1	$342M	Sell	5,985,006 -978,064	-14%	-$55.9M	0.11%	141
2015 Q4	$412M	Buy	6,963,070 +1,071,006	+18%	+$63.4M	0.13%	117
2015 Q3	$321M	Sell	5,892,064 -812,905	-12%	-$44.2M	0.11%	135
2015 Q2	$451M	Sell	6,704,969 -1,897,429	-22%	-$127M	0.14%	112
2015 Q1	$504M	Sell	8,602,398 -299,039	-3%	-$17.5M	0.16%	97
2014 Q4	$583M	Sell	8,901,437 -1,234,931	-12%	-$80.8M	0.18%	72
2014 Q3	$585M	Buy	10,136,368 +2,376,782	+31%	+$137M	0.19%	69
2014 Q2	$438M	Buy	7,759,586 +453,120	+6%	+$25.6M	0.14%	112
2014 Q1	$376M	Sell	7,306,466 -1,109,340	-13%	-$57M	0.12%	128
2013 Q4	$444M	Buy	8,415,806 +1,496,836	+22%	+$79M	0.15%	103
2013 Q3	$309M	Sell	6,918,970 -77,132	-1%	-$3.45M	0.11%	132
2013 Q2	$289M	Buy	+6,996,102	New	+$289M	0.11%	129